Blog
RSS FeedPosted by Michael Wonder on 07 May 2020
CSL Behring Australia commences development of treatment for serious cases of COVID-19
6 May 2020 - Plasma-derived therapeutic with potential to treat serious complications of COVID-19. ...
Posted by Michael Wonder on 06 May 2020
Australia lacks vaccine making capacity, Defence report warns
6 May 2020 - Australia lacks the facilities and know-how to make its own pandemic vaccines, a report to government ...
Posted by Michael Wonder on 06 May 2020
COVID-19: potentially life saving immunoglobulin treatment for seriously ill Australians
6 May 2020 - The Australian Government welcomes the announcement by CSL Behring that Australia will be one of the first ...
Posted by Michael Wonder on 06 May 2020
CSL ramps up development of COVID-19 plasma treatment
6 May 2020 - Australia’s biggest health company CSL has confirmed it will immediately begin development of plasma-derived therapy to ...
Posted by Michael Wonder on 06 Apr 2020
Bill Gates to spend billions on coronavirus vaccine development
5 April 2020 - Foundation to help build factories for the seven makers of the most-promising efforts. ...
Posted by Michael Wonder on 06 Dec 2019
Proposed changes to research and development tax incentive will discourage investment and undermine innovation
6 December 2019 - Medicines Australia is disappointed that proposed changes to the Research and Development Tax Incentive were tabled ...
Posted by Michael Wonder on 26 Oct 2019
Public sector financial support for late stage discovery of new drugs in the United States: cohort study
23 October 2019 - This study determined the extent to which late stage development of new drugs relies on support from ...
Posted by Michael Wonder on 22 Jun 2019
Azar's plan to tie U.S. drug prices to foreign ones will impact investments in R&D
21 June 2019 - Americans, be they Republicans or Democrats, are outraged by the rising cost of prescription drugs. ...
Posted by Michael Wonder on 08 May 2019
Medicines Australia welcomes ALP R&D investment pledge
8 May 2019 - Medicines Australia welcomes today’s announcement from the Australian Labor Party to reform the Research and Development ...
Posted by Michael Wonder on 02 May 2019
FDA advances the science of patient input by seeking specific feedback on patient preferences that may impact regulatory decisions on medical devices
2 May 2019 - The U.S. FDA today opened a docket to receive input from stakeholders on a new priority ...
Posted by Michael Wonder on 21 Jan 2019
China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs
19 January 2019 - New policy environment demanding cheaper drugs adds pressure to innovate. ...
Posted by Michael Wonder on 24 Oct 2017
Medical device development tools: helping to speed medical device evaluation and approval
24 October 2017 - The FDA relies on sound science in its decision-making, which provides medical device innovators with a ...
Posted by Michael Wonder on 24 Oct 2017
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance medical device innovation and help patients gain faster access to beneficial technologies
24 October 2017 - Enabling patients and providers to have efficient access to new and innovative medical products that meet ...
Posted by Michael Wonder on 16 May 2017
Therapeutic Development a key focus of the Roadmap
15 May 2017 - The Medical Technology Association of Australia welcomes the 2016 National Research Infrastructure Roadmap and its recommendations, ...
Posted by Michael Wonder on 15 Mar 2016
Draft clinical evidence guidelines - medical devices
15 March 2016 - The TGA is seeking comments from interested parties on the draft Medical Devices Clinical Evidence Guidelines. ...